157 related articles for article (PubMed ID: 29851165)
1. TGF-β1 alters DNA methylation levels in promoter and enhancer regions of the WT1 gene in human podocytes.
Hamatani H; Sakairi T; Ikeuchi H; Kaneko Y; Maeshima A; Nojima Y; Hiromura K
Nephrology (Carlton); 2019 May; 24(5):575-584. PubMed ID: 29851165
[TBL] [Abstract][Full Text] [Related]
2. TGF-beta1 reduces Wilms' tumor suppressor gene expression in podocytes.
Sakairi T; Abe Y; Kopp JB
Nephrol Dial Transplant; 2011 Sep; 26(9):2746-52. PubMed ID: 21378152
[TBL] [Abstract][Full Text] [Related]
3. The miR-143/145 cluster induced by TGF-β1 suppresses Wilms' tumor 1 expression in cultured human podocytes.
Tabei A; Sakairi T; Hamatani H; Ohishi Y; Watanabe M; Nakasatomi M; Ikeuchi H; Kaneko Y; Kopp JB; Hiromura K
Am J Physiol Renal Physiol; 2023 Jul; 325(1):F121-F133. PubMed ID: 37167274
[TBL] [Abstract][Full Text] [Related]
4. Paracrine Effects of Renal Proximal Tubular Epithelial Cells on Podocyte Injury under Hypoxic Conditions Are Mediated by Arginase-II and TGF-β1.
Ma Y; Potenza DM; Ajalbert G; Brenna A; Zhu C; Ming XF; Yang Z
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835007
[TBL] [Abstract][Full Text] [Related]
5. Murine Denys-Drash syndrome: evidence of podocyte de-differentiation and systemic mediation of glomerulosclerosis.
Patek CE; Fleming S; Miles CG; Bellamy CO; Ladomery M; Spraggon L; Mullins J; Hastie ND; Hooper ML
Hum Mol Genet; 2003 Sep; 12(18):2379-94. PubMed ID: 12915483
[TBL] [Abstract][Full Text] [Related]
6. Role of MiR-155 Signal Pathway in Regulating Podocyte Injury Induced by TGF-β1.
Lin X; Zhen X; Huang H; Wu H; You Y; Guo P; Gu X; Yang F
Cell Physiol Biochem; 2017; 42(4):1469-1480. PubMed ID: 28719898
[TBL] [Abstract][Full Text] [Related]
7. Methylation changes in promoter and enhancer regions of the WT1 gene in Wilms' tumours.
Mares J; Kríz V; Weinhäusel A; Vodicková S; Kodet R; Haas OA; Sedlácek Z; Goetz P
Cancer Lett; 2001 May; 166(2):165-71. PubMed ID: 11311489
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of TRPC6 Signal Pathway Alleviates Podocyte Injury Induced by TGF-β1.
Huang H; You Y; Lin X; Tang C; Gu X; Huang M; Qin Y; Tan J; Huang F
Cell Physiol Biochem; 2017; 41(1):163-172. PubMed ID: 28214865
[TBL] [Abstract][Full Text] [Related]
9. PINCH1 is transcriptional regulator in podocytes that interacts with WT1 and represses podocalyxin expression.
Wang D; Li Y; Wu C; Liu Y
PLoS One; 2011 Feb; 6(2):e17048. PubMed ID: 21390327
[TBL] [Abstract][Full Text] [Related]
10. [Transcriptional activity of WT1 gene promoter and enhancer in diverse cell lines].
Hu SY; Chen ZX; Zhao Y; Cen JN; Gu M; Fu ZZ; He J; Gu WY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):1050-5. PubMed ID: 17956689
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic Regulation of Caveolin-1 Gene Expression in Lung Fibroblasts.
Sanders YY; Liu H; Scruggs AM; Duncan SR; Huang SK; Thannickal VJ
Am J Respir Cell Mol Biol; 2017 Jan; 56(1):50-61. PubMed ID: 27560128
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor β1 induces the expression of collagen type I by DNA methylation in cardiac fibroblasts.
Pan X; Chen Z; Huang R; Yao Y; Ma G
PLoS One; 2013; 8(4):e60335. PubMed ID: 23560091
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-466o-3p mediates β-catenin-induced podocyte injury by targeting Wilms tumor 1.
Chen Q; Chen J; Wang C; Chen X; Liu J; Zhou L; Liu Y
FASEB J; 2020 Nov; 34(11):14424-14439. PubMed ID: 32888352
[TBL] [Abstract][Full Text] [Related]
14. Impaired transcription factor interplay in addition to advanced glycation end products suppress podocalyxin expression in high glucose-treated human podocytes.
Drossopoulou GI; Tsotakos NE; Tsilibary EC
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F594-603. PubMed ID: 19605546
[TBL] [Abstract][Full Text] [Related]
15. Repression of CMIP transcription by WT1 is relevant to podocyte health.
Moktefi A; Zhang SY; Vachin P; Ory V; Henique C; Audard V; Rucker-Martin C; Gouadon E; Eccles M; Schedl A; Heidet L; Ollero M; Sahali D; Pawlak A
Kidney Int; 2016 Dec; 90(6):1298-1311. PubMed ID: 27650733
[TBL] [Abstract][Full Text] [Related]
16. Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria.
Li Y; Kang YS; Dai C; Kiss LP; Wen X; Liu Y
Am J Pathol; 2008 Feb; 172(2):299-308. PubMed ID: 18202193
[TBL] [Abstract][Full Text] [Related]
17. Control of epigenetic states by WT1 via regulation of de novo DNA methyltransferase 3A.
Szemes M; Dallosso AR; Melegh Z; Curry T; Li Y; Rivers C; Uney J; Mägdefrau AS; Schwiderski K; Park JH; Brown KW; Shandilya J; Roberts SG; Malik K
Hum Mol Genet; 2013 Jan; 22(1):74-83. PubMed ID: 23042785
[TBL] [Abstract][Full Text] [Related]
18. [Study on DNA methylation status of WT1 gene in its promoter region in hematologic malignancy cell lines].
Zhao Y; Chen ZX; Hu SY; Cen JN; Gu WY
Zhonghua Xue Ye Xue Za Zhi; 2005 Sep; 26(9):517-20. PubMed ID: 16468326
[TBL] [Abstract][Full Text] [Related]
19. Functional switching of TGF-beta1 signaling in liver cancer via epigenetic modulation of a single CpG site in TTP promoter.
Sohn BH; Park IY; Lee JJ; Yang SJ; Jang YJ; Park KC; Kim DJ; Lee DC; Sohn HA; Kim TW; Yoo HS; Choi JY; Bae YS; Yeom YI
Gastroenterology; 2010 May; 138(5):1898-908. PubMed ID: 20038433
[TBL] [Abstract][Full Text] [Related]
20. The Epigenetically-Regulated microRNA-378a Targets TGF-β2 in TGF-β1-Treated Hepatic Stellate Cells.
Yu F; Yang J; Huang K; Pan X; Chen B; Dong P; Zheng J
Cell Physiol Biochem; 2016; 40(1-2):183-194. PubMed ID: 27855367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
